Alpha Signal Monitor - Daily Market Briefing | April 09, 2026
Daily Market Research Report
April 09, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Gold ETFs: Institutional Outlook Snapshot (as of April 9, 2026)
Trading Idea: Buy Rationale (TL;DR): Major houses now project gold near/above $5,000/oz into late‑2026 on persistent central‑bank buying, renewed private‑sector diversification, and an easier global rates backdrop. Pullbacks notwithstanding, the modal path remains higher; broad bank targets cluster in the mid‑$4,000s to low‑$6,000s for 2026, supporting long gold ETF exposure (GLD/IAU/BAR). (investing.com)
Gold printed fresh all‑time highs in late January 2026, with banks citing EM central‑bank demand, private‑sector diversification and prospective Fed easing as the key pillars for elevated prices through 2026. Several institutions formalized higher 2026 targets between ~$5,000 and ~$6,200/oz, reinforcing the constructive setup for physically backed ETFs. (moneyweek.com)
Key Drivers - Emerging‑market central‑bank buying remains a dominant, price‑insulating flow. - Private‑sector diversification into bullion/ETFs alongside macro policy and geopolitical hedging. - Easier policy rates/lower real yields vs. 2023–24, plus periodic USD softness. - Constrained mine supply growth and limited near‑term project pipeline. - ETF wrappers (GLD/IAU/BAR) provide direct spot exposure with scale/liquidity (GLD) or lower fees (IAU/BAR).
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | $5,400/oz (Dec‑2026 target) | Raised YE‑2026 forecast to $5,400, citing continued private‑sector diversification into bullion and strong EM central‑bank demand. | 2026-01-22 | https://www.bloomberg.com/news/articles/2026-01-22/goldman-sachs-raises-year-end-gold-forecast-to-5-400-an-ounce |
| Morgan Stanley | Positive | $4,800/oz by Q4‑2026 (latest); earlier base raised to ~$4,400 for 2026 | Forecasts gold at $4,800 by Q4‑2026; prior research lifted 2026 base case to ~$4,400 on persistent CB/ETF demand and easier policy. | 2026-01-06 | https://www.investing.com/news/commodities-news/morgan-stanley-forecasts-gold-at-4800-by-fourth-quarter-of-2026-4432140 |
| JP Morgan | Bullish | Avg ~$5,055/oz in Q4‑2026 (bank quarterly path) | Global Research baseline shows 2026 quarterly averages rising through the year, reaching ~$5,055/oz in Q4‑2026. | - | https://www.jpmorgan.com/insights/global-research/commodities/gold-prices |
| Bank of America | Bullish | $5,000/oz in 2026 (with ~${4,400}/oz 2026 average) | BofA Global Research raised its 2026 outlook to $5,000/oz; framework notes a mid‑$4,000s annual average with volatility risk. | 2025-10-13 | https://www.investing.com/news/economy-news/factboxbofa-hikes-gold-price-forecast-to-5000oz-for-2026-4283688 |
| Citigroup | Neutral/Cautious | - | Citi’s 2026 ‘Prospects’ notes gold at ~$4,200 isn’t a “great bullish trade,” favoring select precious/industrial metals while maintaining strategic exposure. | 2025-12-01 | https://www.citigroup.com/global/insights/prospects-for-2026-goldilocks-performance-but-risks-linger |
| UBS | Positive | $5,900–$6,200/oz across 2026 (moderating toward $5,900 by year‑end) | UBS CIO outlines a 2026 path centered near $6,200/oz for much of the year, with persistent CB purchases and diversification demand. | 2026-03-12 | https://www.ubs.com/global/en/wealthmanagement/insights/chief-investment-office/house-view/2026/weekly-key-messages/_jcr_content/root/contentarea/mainpar/toplevelgrid_1825995/col_2/textimage_copy_442954538.1156723570.file/dGV4dD0vY29udGVudC9kYW0vYXNzZXRzL3dtL2dsb2JhbC9jaW8vaG91c2Utdmlldy9kb2N1bWVudC9nb2xkLXdhci1wYXJhZG94LnBkZg==/gold-war-paradox.pdf |
| HSBC | Constructive (with volatility) | 2026 average ~$4,587/oz; upside risk toward $5,000/oz | HSBC’s precious‑metals team trimmed the 2026 average near $4.6k but flagged upside scenarios to ~$5k on geopolitics/fiscal risks. | 2026-01-08 | https://za.investing.com/news/commodities-news/gold-may-hit-5000oz-in-1h26--hsbc-4052863 |
| Deutsche Bank | Positive/Base with high‑side scenario | Base: ~$4,000/oz 2026 avg (Sep‑2025); Upside: ~$6,000/oz in 2026 (Jan‑2026) | DB lifted its 2026 base average to ~$4,000/oz; later suggested $6,000 is achievable in 2026 on weaker USD and strong investment/CB flows. | 2026-01-27 | https://za.investing.com/news/stock-market-news/factboxdeutsche-bank-sees-gold-climbing-to-6000oz-in-2026-4080822 |
Risk Considerations - A stronger USD and/or higher real yields could compress fair value and trigger ETF outflows. - A slowdown or reversal in central‑bank purchases; potential official‑sector sales. - Faster‑than‑expected disinflation and soft‑landing risk rotation away from hedges. - Geopolitical de‑escalation reducing risk premia; volatility and flash‑crash episodes. - Liquidity or market‑structure shocks that widen tracking spreads near stress events.
Implementation: accumulate gold ETF exposure on pullbacks; use GLD for deep liquidity and IAU/BAR for lower expense ratios. Expect elevated volatility but maintain long bias into late‑2026 given institutional targets and demand mix. (investing.com)
Stock Ratings — U.S. Large‑Cap Tech — Street Targets and Ratings Snapshot (GS/MS/JPM/BAC/C/WFC) as of April 9, 2026
Below is a stock-by-stock organization of the latest publicly reported price targets and ratings from Goldman Sachs (GS), Morgan Stanley (MS), JPMorgan (JPM), Bank of America (BAC), Citigroup (C), and Wells Fargo (WFC). Where a bank’s most recent target or rating could not be verified from public sources, fields are left null. Consensus figures are computed only from the institutions with available data in each row.
AAPL - Apple Inc.
Most bulge-bracket banks remain constructive into the 2026 product/AI cycle; BAC trimmed its PT in March while MS reiterated Overweight.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-03-02 | Reiterated Buy; MarketBeat item did not display a PT. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Morgan Stanley | Overweight | $315 | 2026-03-23 | Reiterated Overweight; kept PT at $315. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| JP Morgan | Overweight | $325 | 2026-01-30 | Raised PT $315 → $325; reiterated Overweight. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Bank of America | Buy | $320 | 2026-03-23 | Trimmed PT $325 → $320; reiterated Buy. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Citigroup | Buy | $315 | 2026-01-02 | Lowered PT $330 → $315; reiterated Buy. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Overweight | $300 | 2025-10-31 | Raised PT $290 → $300; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Buy, Target Price: $315 - Average of available PTs (MS, JPM, BAC, C, WFC) = ~$315; majority Buy/Overweight.
MSFT - Microsoft Corporation
BAC initiated with Buy and a $500 PT in late March; several banks trimmed mega-cap software targets in late January.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-02-12 | Reiterated Buy; PT not shown in MarketBeat snippet. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Morgan Stanley | Overweight | - | 2026-01-29 | Reiterated Overweight; PT not shown in snippet. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| JP Morgan | Overweight | $550 | 2026-01-29 | Cut PT $575 → $550; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Bank of America | Buy | $500 | 2026-03-24 | Initiated coverage with Buy and $500 PT (Tal Liani). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Buy | $635 | 2026-01-29 | Lowered PT $660 → $635; Buy. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Overweight | $615 | 2026-01-29 | Lowered PT $630 → $615; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Buy, Target Price: $575 - Average of available PTs (BAC, JPM, C, WFC) ≈ $575; majority Buy/Overweight.
GOOGL - Alphabet Inc.
Multiple PT increases around early February; WFC trimmed its target in March.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $375 | 2026-01-13 | Reiterated Buy; lifted PT to $375. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | Overweight | $330 | 2025-10-30 | Raised PT $270 → $330; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | Buy | - | 2026-02-06 | Reiterated Buy; PT not shown in snippet. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Bank of America | Buy | $370 | 2025-12-02 | Raised PT $335 → $370; Buy. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Citigroup | Buy | $390 | 2026-02-06 | Raised PT $350 → $390; Buy. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Overweight | $361 | 2026-03-06 | Lowered PT $397 → $361; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Buy, Target Price: $365.20 - Average of available PTs (GS, MS, BAC, C, WFC) ≈ $365.20; majority Buy/Overweight.
AMZN - Amazon.com, Inc.
Post-earnings February reset saw several PT trims; JPM lifted its PT and rating to Overweight in March; WFC nudged PT to $305 at month-end.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $300 | 2026-01-01 | Raised PT $290 → $300; Buy. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Morgan Stanley | Overweight | $300 | 2026-02-06 | Reiterated Overweight; cut PT $315 → $300. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | Overweight | $280 | 2026-03-23 | Raised PT $265 → $280; moved to Overweight. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | Buy | $286 | 2026-01-26 | Lowered PT $303 → $286; Buy. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | - | - | - | Recent public PT not shown on MarketBeat item during period reviewed. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Overweight | $305 | 2026-03-30 | Raised PT $304 → $305; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: $294.20 - Average of available PTs (GS, MS, JPM, BAC, WFC) ≈ $294.20; majority Buy/Overweight.
NVDA - NVIDIA Corporation
Across banks, targets broadly reset higher around late Feb. after results/GTC; BAC and Citi at $300; GS at $250; MS at $260; JPM at $265.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $250 | 2026-02-25 | Set PT $250; Buy. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Morgan Stanley | Overweight | $260 | 2026-03-02 | Set PT $260; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| JP Morgan | Overweight | $265 | 2026-02-26 | Raised PT $250 → $265; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Bank of America | Buy | $300 | 2026-02-25 | Raised PT $275 → $300; Buy. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Citigroup | Buy | $300 | 2026-02-26 | Raised PT $270 → $300; Buy. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Wells Fargo | Overweight | - | 2025-11-28 | Reiterated Overweight; PT not shown in snippet. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
Consensus View - Rating: Buy, Target Price: $275.00 - Average of available PTs (GS, MS, JPM, BAC, C) = $275; strong Buy/Overweight skew.
META - Meta Platforms, Inc.
Street consensus remains constructive; bank-specific public summaries were not visible in MarketBeat snippets for the period reviewed.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
Consensus View - Insufficient bank-specific entries to compute a 6‑bank consensus. Street-wide consensus on MarketBeat shows ~$843.57 and Moderate Buy, but that is broader than the requested six banks.
TSLA - Tesla, Inc.
Coverage list confirms all six banks, but recent bank-specific PT/rating lines were not visible in MarketBeat snippets reviewed.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
Consensus View - Insufficient bank-specific entries to compute a 6‑bank consensus. Street-wide consensus on MarketBeat shows ~$400.44 and Hold, but that is broader than the requested six banks.
AVGO - Broadcom Inc.
Following March updates, BAC trimmed its PT to $450; WFC upgraded to Overweight with a higher PT in January.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Bank of America | Buy | $450 | 2026-03-05 | Lowered PT $500 → $450; Buy. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Wells Fargo | Overweight | $430 | 2026-01-09 | Upgraded Equal Weight → Overweight; raised PT $410 → $430. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
Consensus View - Rating: Buy, Target Price: $440 - Simple average of available BAC and WFC PTs ≈ $440; indicative only given 2/6 banks.
TSM - Taiwan Semiconductor Manufacturing Company Limited
Street consensus remains positive; bank-specific entries for the six U.S. institutions not clearly listed in public snippets reviewed.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
Consensus View - Insufficient bank-specific entries to compute a 6‑bank consensus. Street-wide consensus on MarketBeat shows ~$391 and Buy, but that is broader than the requested six banks.
Highlights
- Most recent actionable changes: AAPL (BAC trim to $320 on 2026-03-23; MS reiteration $315 on 2026-03-23), AMZN (JPM upgrade/raise to $280 on 2026-03-23; WFC to $305 on 2026-03-30), NVDA (BAC/Citi to $300 on 2026-02-25/26; MS set $260 on 2026-03-02), GOOGL (WFC trim to $361 on 2026-03-06).
- Where MarketBeat public snippets lacked a visible price target (common for some reiterations), the entry is included with rating/date and target set to null.
- Consensus rows reflect only the subset of the six requested banks with visible targets; for broader Street consensus (all covering firms), see each MarketBeat page’s headline consensus.
Sources: All entries were compiled from the respective MarketBeat analyst forecast pages for each ticker on April 9, 2026. If you’d like, I can extend this with direct-bank PDF notes or alternative public syndication (The Fly/Reuters/CNBC/Benzinga) to fill remaining nulls and cross-verify targets and timestamps.
IPO Calendar
Timeframe: April 9, 2026 – May 9, 2026 (US equity markets)
The next month’s US IPO slate features a mix of large, brand‑name industrials/defense (Madison Air Solutions; Arxis), several micro‑cap/SME NYSE American listings, and a continuing trickle of SPACs. If Madison Air prices as filed (~$2.15B gross at the range mid), it would be the largest US IPO YTD; Arxis is targeting ~$1.0B. Dates for small‑cap deals are especially tentative and can move intra‑week. Note that a critical‑minerals royalty company (TMCR) completed a Nasdaq direct listing on April 8, 2026 (just before this window), and additional industrial/energy names (e.g., X‑energy) have filed and could launch quickly depending on markets. Sources for schedules/terms include the live Renaissance Capital calendar and issuer/SEC materials. (renaissancecapital.com)
QuasarEdge Acquisition Corporation (QREDU (units) / QRED (shares))
- Expected listing date: 2026-04-09
- Price range: $10.00 per unit (SPAC)
- Shares offered: 10,000,000 units (+1,500,000 overallotment)
- Exchange: NYSE
- Lead underwriters: Polaris Advisory Partners (a division of Kingswood Capital Partners LLC) – sole bookrunner
- Business summary: Blank-check company (Cayman) targeting businesses with durable growth and defensible moats; units comprise 1 ordinary share plus a right to receive one‑fourth of a share upon business combination.
- Notes: Issuer anticipates NYSE listing of units, with shares/rights to separate post‑IPO per prospectus. Schedule/size subject to market conditions. Source prospectus names NYSE symbols QREDU/QRED/QREDUR. (sec.gov)
- Sources: SEC EDGAR – Form S‑1 (QuasarEdge Acquisition Corp., filed Mar 2026), Renaissance Capital – Upcoming IPO Calendar (accessed Apr 9, 2026)
Encore Medical, Inc. (EMI)
- Expected listing date: 2026-04-15
- Price range: $5.00 per share (assumed offering price in S‑1/A)
- Shares offered: 3,000,000 shares (+450,000 overallotment)
- Exchange: NYSE American
- Lead underwriters: The Oak Ridge Financial Services Group, Inc. (representative), Dawson James Securities, Inc.
- Business summary: Structural heart medical‑device company developing septal occlusion technologies (e.g., for PFO). Proceeds fund US clinical trials, working capital, and general corporate purposes.
- Notes: Date/size can move; NYSE American application disclosed in S‑1/A. Underwriters and 8% underwriting fee, rep’s warrant, and 45‑day greenshoe disclosed in filing. (sec.gov)
- Sources: SEC EDGAR – Form S‑1/A (Encore Medical, filed Mar 2026), StockAnalysis – IPO Calendar (accessed Apr 9, 2026)
Arxis, Inc. (ARXS)
- Expected listing date: 2026-04-16 (expected)
- Price range: $25.00 – $28.00 per share
- Shares offered: 37,735,849 shares (+ underwriters’ option)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: Goldman Sachs & Co. LLC (lead joint bookrunner), Morgan Stanley (lead joint bookrunner), Jefferies (lead joint bookrunner), Citigroup, RBC Capital Markets (joint bookrunners), Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co, Wolfe | Nomura Alliance (bookrunners), Citizens Capital Markets (co‑manager)
- Business summary: Designer/manufacturer of mission‑critical electronic and mechanical components for aerospace/defense, med‑tech and specialized industrial markets; PE‑backed (Arcline).
- Notes: Issuer launched roadshow Apr 8; trade date not formally announced but calendars show Apr 16. Timing/size subject to effectiveness and markets. (prnewswire.com)
- Sources: PR Newswire – Arxis announces launch of its IPO (Apr 8, 2026), Renaissance Capital – US IPO Week Ahead (Apr 2, 2026), StockAnalysis – IPO Calendar (accessed Apr 9, 2026), Reuters via Investing.com coverage (Apr 8, 2026)
Madison Air Solutions Corporation (MAIR)
- Expected listing date: 2026-04-16 (expected)
- Price range: $25.00 – $27.00 per share
- Shares offered: 82,692,308 shares (+ underwriters’ option)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC (joint lead bookrunner), Barclays (joint lead bookrunner), Jefferies (joint lead bookrunner), Wells Fargo Securities (joint lead bookrunner), BofA Securities, Citigroup, Baird, RBC Capital Markets, Guggenheim Securities, Santander, Wolfe | Nomura Alliance, CIBC Capital Markets (joint bookrunners), Comerica Securities, William Blair, Stifel, Capital One Securities, PNC Capital Markets LLC (co‑managers)
- Business summary: Global indoor air quality and air‑management platform with brands including Nortek Air Solutions, Nortek Data Center Cooling, AprilAire, Big Ass Fans, Broan‑NuTone and Reznor; proceeds earmarked to repay debt.
- Notes: Company launched roadshow Apr 6; date not in the issuer PR but independent calendars show Apr 16 (subject to change). Would be the largest US IPO YTD if it prices at the filed range. (prnewswire.com)
- Sources: PR Newswire – Madison Air launches roadshow (Apr 6, 2026), StockAnalysis – IPO Calendar (accessed Apr 9, 2026), Renaissance Capital news item on terms (Apr 6–8, 2026)
BW Industrial Holdings Inc. (BWGC)
- Expected listing date: 2026-04-17 (expected)
- Price range: $6.00 – $7.00 per share (recent range)
- Shares offered: 2,625,000 shares (+393,750 overallotment)
- Exchange: NYSE American
- Lead underwriters: Eddid Securities USA Inc. (representative and sole underwriter)
- Business summary: Engineering, procurement and construction (EPC) services provider for critical process systems across energy storage, renewables infrastructure, electronics/advanced manufacturing and semiconductor facilities (via Bestwater USA subsidiary).
- Notes: Underwriting section of S‑1/A names Eddid as representative and sole underwriter; schedule and range subject to change. (sec.gov)
- Sources: SEC EDGAR – Form S‑1/A (BW Industrial Holdings, Mar/Apr 2026), StockAnalysis – IPO Calendar (accessed Apr 9, 2026)
Riku Dining Group Limited (RIKU)
- Expected listing date: 2026-04-24 (expected)
- Price range: $4.00 – $6.00 per share
- Shares offered: 5,000,000 shares
- Exchange: Nasdaq Capital Market
- Lead underwriters: Eddid Securities USA Inc. (lead manager per filing tracker)
- Business summary: Operator/franchisor of Japanese‑themed restaurant concepts in Canada and Hong Kong; revenues from company‑operated stores, franchise royalties/fees, management services and food‑ingredient sales to franchisees.
- Notes: Recent F‑1/A upsized the deal to 5.0M shares; listing date shown on third‑party calendars and can shift. (tradingview.com)
- Sources: SEC F‑1/A summary via TradingView News (Mar 2026), StockAnalysis – IPO Calendar (accessed Apr 9, 2026), CCH IPO Tracker note listing Eddid as first lead (Sept 16, 2025)
Salspera, Inc. (TKVA (proposed))
- Price range: $14.00 – $16.00 per share
- Shares offered: 5,666,666 primary shares (+850,000 overallotment)
- Exchange: Nasdaq (applied)
- Lead underwriters: Kingswood Capital Partners, LLC (sole bookrunner)
- Business summary: Clinical‑stage immuno‑oncology company developing live bacterial therapeutics for solid tumors; lead candidate Saltikva (attenuated Salmonella expressing IL‑2) moving toward a Phase 3 program; proceeds to fund trials and working capital.
- Notes: Issuer set terms and targeted week of Mar 23, 2026 for pricing; as of early April the registration was not yet effective and timing appears delayed (potential April launch, but TBD). (sec.gov)
- Sources: SEC EDGAR – Issuer Free Writing Prospectus (Mar 2026), Renaissance Capital – Salspera profile/calendar (accessed Apr 9, 2026)
X‑energy, Inc. (XE (proposed))
- Exchange: Nasdaq Global Select Market (intended)
- Lead underwriters: J.P. Morgan, Morgan Stanley, Jefferies, Moelis & Company (lead joint book‑running managers)
- Business summary: Advanced nuclear company developing the Xe‑100 high‑temperature gas‑cooled small modular reactor (SMR) and TRISO‑X fuel; aiming to serve growing baseload and data‑center power needs with modular, intrinsically safe nuclear.
- Notes: Company announced submission of a draft S‑1 on Mar 20, 2026; number of shares and price range not yet set; launch timing subject to SEC review and markets. (x-energy.com)
- Sources: Issuer press release – X‑energy submits draft S‑1 and intends to list as ‘XE’ on Nasdaq (Mar 20, 2026)
IPO calendars change rapidly; dates are best estimates as of April 9, 2026. “Expected” dates (e.g., Apr 16 for MAIR/ARXS; Apr 17 for BWGC; Apr 24 for RIKU) are shown on third‑party calendars and can move or slip; always confirm night‑of‑pricing. Micro‑cap and SPAC deals especially are prone to day‑of adjustments. Primary reference calendars and issuer/SEC materials are cited above. (stockanalysis.com)
Sources
- Stock Ratings: https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/, https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
- IPO Calendar: https://stockanalysis.com/ipos/calendar/, https://www.prnewswire.com/news-releases/arxis-announces-launch-of-its-initial-public-offering-302736959.html, https://www.prnewswire.com/news-releases/madison-air-launches-roadshow-for-proposed-initial-public-offering-302734681.html, https://www.renaissancecapital.com/IPO-Center/Calendar, https://www.sec.gov/Archives/edgar/data/0001838003/000110465926022408/tm2525595-6_s1a.htm, https://www.sec.gov/Archives/edgar/data/2080841/000121390026028518/ea0252378-07.htm, https://www.sec.gov/Archives/edgar/data/2084032/000121390026023531/ea0279573-fwp_salspera.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2085177/000182912626001942/quasaredgeacq_s1.htm, https://www.tradingview.com/news/tradingview%3Ad0b333d5726cf%3A0-riku-dining-group-operator-of-japanese-themed-restaurants-across-canada-and-hong-kong-with-franchised-and-self-operated-brands-files-for-nasdaq-capital-market-ipo/?utm_source=openai, https://x-energy.com/news/x-energy-submits-draft-registration-statement-to-sec-for-ipo/
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-04-09 at 11:32 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI